torrat and Hypertension

torrat has been researched along with Hypertension* in 6 studies

Trials

3 trial(s) available for torrat and Hypertension

Article	Year
[The advantage of hypertension therapy with a once-daily beta-blocker-diuretic combination]. Medizinische Klinik, 1981, Aug-28, Volume: 76, Issue:18 Topics: Blood Pressure; Drug Administration Schedule; Drug Combinations; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Metipranolol; Middle Aged; Propanolamines	1981
[Intraindividual comparison between 1 tablet BM 02.004 and 1 tablet of torrat twice daily in the long-term treatment of hypertension]. Therapie der Gegenwart, 1981, Volume: 120, Issue:12 Topics: Administration, Oral; Adult; Aged; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metipranolol; Middle Aged; Propanolamines	1981
Comparison of the antihypertensive effect of metipranolol, butizide and torrat in Kenyan Africans. East African medical journal, 1981, Volume: 58, Issue:11 Topics: Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Kenya; Male; Metipranolol; Middle Aged; Propanolamines	1981

Other Studies

3 other study(ies) available for torrat and Hypertension

Article	Year
[Treatment of arterial hypertension with torrat in general practice]. Therapie der Gegenwart, 1979, Volume: 118, Issue:7 Topics: Drug Combinations; Drug Evaluation; Humans; Hydrochlorothiazide; Hypertension; Metipranolol; Potassium; Propanolamines	1979
[Metabolic effects of a fixed combination (betablocker plus saluretic) in long-term treatment of arterial hypertension (author's transl)]. Medizinische Klinik, 1979, Jun-08, Volume: 74, Issue:23 In 23 patients with essential hypertension of stage I and II according to the WHO, the effects of a fixed combination of a beta-receptor-blocker plus saluretic composed of 20 mg of metipranolol (Disorat 20) and 2.5 mg of butizid (Saltucin) = Torrat on blood pressure and important metabolic parameters (glucose, glucose tolerance, cholesterol, triglyceride, uric acid, plasma potassium and whole body potassium) were tested over a 6-month treatment period.. blood pressure and pulse rate were significantly reduced; bradycardia (pulse rate less than 60/min) was not observed. The metabolic parameters showed no significant changes during the 6-month treatment period. In no case did the therapy have to be discontinued because of undesirable effects. The investigations show that the combination has a good antihypertensive effect with few side-effects and that it has no influence on important metabolic parameters during long-term therapy. Topics: Adult; Blood Glucose; Blood Pressure; Cholesterol; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Long-Term Care; Male; Metipranolol; Middle Aged; Potassium; Propanolamines; Time Factors; Triglycerides; Uric Acid	1979
[Results of a study with the antihypertensive agent Torrat]. Therapie der Gegenwart, 1978, Volume: 117, Issue:12 Topics: Adult; Aged; Antihypertensive Agents; Drug Combinations; Drug Evaluation; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metipranolol; Middle Aged; Propanolamines	1978